Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
  • Donate
Select Page
The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age

by Admin | Jul 15, 2021 | News & Opinions

By: William A. Haseltine – Forbes.com  – link to Article IMAGE CAPTION – 3D printed organ scaffolds by Wake Forest Institute for Regenerative Medicine is displayed as part of the ‘AI: More than Human’ exhibition at the Barbican Curve...
The Memphis Institute of Regenerative Medicine Rebrands To Reflect Statewide Reach

The Memphis Institute of Regenerative Medicine Rebrands To Reflect Statewide Reach

by Admin | Jul 14, 2021 | News & Opinions

Written by Lee Ferguson July 13, 2021 – A cutting-edge University of Tennessee Health Science Center institute, the Memphis Institute of Regenerative Medicine, is rebranding to reflect its growing reach across the state. Effective this month, it will be known as...
ISS National Lab to Host Session at World Stem Cell Summit on Regenerative Medicine in Low Earth Orbit

ISS National Lab to Host Session at World Stem Cell Summit on Regenerative Medicine in Low Earth Orbit

by Admin | Jun 15, 2021 | News & Opinions

The International Space Station (ISS) U.S. National Laboratory will host a panel of industry experts on the impacts of health, aging, and human survival research onboard the orbiting laboratory at the World Stem Cell Summit. This annual event brings together noted...
Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction

Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction

by Admin | Jun 14, 2021 | News & Opinions

SenlangBio, a world-class cell therapy company, has developed a robust pipeline which includes 15 autologous and universal (“off-the-shelf”) CAR-T and CAR-γδT cell therapy candidates targeting hematologic malignancies and solid tumors SenlangBio’s lead CAR-T...
Avalon GloboCare to Present at the Noble Capital Markets Investor Forum During the 16th Annual World Stem Cell Summit on June 17, 2021

Avalon GloboCare to Present at the Noble Capital Markets Investor Forum During the 16th Annual World Stem Cell Summit on June 17, 2021

by Admin | Jun 11, 2021 | News & Opinions

FREEHOLD, N.J., June 11, 2021 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced that it will be presenting at the Noble Capital Markets...
Avalon GloboCare To Present Its S-Layer and QTY Code Breakthrough Technology Platforms at The Prestigious Annual World Stem Cell Summit

Avalon GloboCare To Present Its S-Layer and QTY Code Breakthrough Technology Platforms at The Prestigious Annual World Stem Cell Summit

by Admin | Jun 8, 2021 | News & Opinions

FREEHOLD, N.J., June 08, 2021 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announces that the company’s President and Chief Executive...
Page 172 of 216« First«171172173»Last »

Recent Posts

  • New RNA injection could help hearts heal after heart attacks
  • Japan Approves the World’s First Treatment Made With Reprogrammed Human Cells
  • With FDA go ahead, a China biotech notches a first in cell therapy testing
  • FDA must regulate stem cell therapies to mitigate risks to patients and the public
  • Gene-based therapies poised for major upgrade thanks to Oregon State University research
Tweets about @WSCSummit